Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases

Technology appraisal guidance
Reference number: TA412
Published: 28 September 2016

History

Expected publication

Equality Impact Assessment (Guidance development) (PDF 163 KB)

Published:

30 September 2016

Final appraisal determination: 1

Final appraisal determination: 1
Final appraisal determination document (PDF 228 KB)

Published:

02 September 2016
Committee papers (PDF 1.6 MB)

Published:

02 September 2016